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ABSTRACT
The way that soldiers are injured in modern conflicts has changed. Bullet and
ballistic weapons are causing fewer casualties, and more commonly Improvised
Explosive Devices (IED) are injuring them. The purpose of this thesis is to
characterize the injury pattern of the antipersonnel IED (AP-IED) in victims from
the Afghanistan conflict, to retrospectively examine the incidence and type of
vascular trauma in a Canadian level 1 trauma center and to develop and novel
device for control of junctional vascular injuries.

The injury pattern of 100 consecutive AP-IED victims was recorded. Multiple
amputations occurred in 70% of IED victims: 5 quadruple amputations, 27 triple
amputations, and 38 double amputations. Pelvic fractures occurred in 21 victims
and severe perineal, gluteal or genital injuries were present in 46 patients. The
casualty fatality rate was 19%.

All adult trauma patients who presented to a Canadian Level I trauma centre with injuries
to named arterial or venous vessels from 1 January 2011- 31 December 2015 were
reviewed. The majority of patients were male (70.1%) with an injury severity score of 15
or greater in 63.3%. Blunt mechanism accounted for 61.4%. Vessel injuries to the neck
(20.4%), thorax (20.4%), abdomen/pelvis (19.7%), upper extremity (24.5%) and
lower extremity (15.0%) were identified. Prehospital tourniquet use for arterial
injuries occurred in 12.2%. Non-operative management was used in 39 patients
(28.3%) and open and endovascular repair were undertaken on 59 (42.8%) and 17
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(12.3%) respectively. No temporary intravascular shunts or balloon aortic occlusion
devices were used. Thirteen different subspecialty disciplines managed vascular
trauma at this centre.

A novel device for the control of pelvic and junctional hemorrhage was developed
and tested in porcine and human cadavers. Placement of a catheter into the femoral
vessel was followed by expression of the balloon with inflation by CO2 in a proximal
direction. Thus it can navigate and treat damaged pelvic vasculature, occluding the
distal aorta, and is technically simple to use. This CO2 balloon system was tested on
model aortas with inline fluid flow and pressure monitoring to determine the
maximum pressure the balloons could occlude. The device was tested on both intact
and injured cadaveric porcine aortas for its ability to occlude fluid flow and to test
the devices safety for use in arteries. The device was tested on a dye-perfused
human cadaveric model. The results of the study indicate the device can occlude
fluid flow to supra-physiologic pressures and will rupture before injuring the vessel
in the event of over inflation. It has the advantage of being able to navigate and treat
injured pelvic vessels and is easy to use. This device may provide a tool to
community hospitals and forward medical care providers in managing noncompressible pelvic hemorrhage.
Key words: blast, trauma, vascular injury, improvised explosive device, military.
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CHAPTER 1

INTRODUCTION
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CHAPTER 1: INTRODUCTION
1.1 Introduction
Between January 2002 and until March 2014 Canadian soldiers were in Afghanistan,
first in a combat role fighting the Taliban and al-Qaeda, then in a training role
preparing the Afghan National Army. More than 40,000 Canadian soldiers would
serve in Afghanistan during this conflict and Canada would suffer its first combat
casualties since the Korean War. 158 Canadian Armed Forces soldiers died
including Captain Nichola Goddard, the first female Canadian soldier to ever die in
combat.1

This war presented a change in the way Canadian soldiers were injured. The
majority of the people injured in this war were not harmed by bullets and
conventional fighting but by Improvised Explosive Devices (IEDs).2,3 IEDs are
explosives, either taken from conventional weapons and repurposed, or created de
novo. They then are detonated either by remote control, a pressure plate, or a trip
wire to explode and injure or kill their target. These custom-made bombs may be
used to attack vehicles, large crowds, or a dismounted soldier walking on patrol.4
This change in the way our solders are attacked has changed the type of injuries
treated by our combat hospitals.5-7

In treating these IED casualties combat surgeons needed to become adept at
vascular damage control surgery. Canadian surgeons treating trauma patients in
Kandahar, Afghanistan reported over 100 vascular repairs between 2005 and
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2010.8 The use of tourniquets, temporary intravascular shunts and aggressive
vascular ligation became commonplace. The Afghanistan war changed the way
military surgeons treat vascular trauma patients.9

Most of the changes in vascular trauma care were made out of necessity and
adaptations to the casualties the surgeons were receiving. In order to prospectively
monitor outcomes the Joint Theatre Trauma Registry was developed. As these
deployed surgeons returned home they brought with them their experiences
managing vascular trauma from combat. The American Association for the Surgery
of Trauma (AAST) sponsored the Prospective Observational Vascular Injury
Treatment Registry (PROOVIT) in order to document changes in treatment of
American vascular trauma and monitor outcomes. 10

Although much has been published about the medical experience in the Afghanistan
war there remains several unanswered problems. What is the medical description
of the injury pattern of the IED? Do combat damage control vascular techniques
apply to a Canadian trauma population? Is there any novel way we can gain
hemorrhagic control of the vascular trauma injured patient that is fast, safe and easy
to use? It is the purpose of this thesis to address these three questions.

In order to be able to prepare for combat we must understand the way we are being
attacked. In order to be prepared to treat our casualties we must know the nature
of the injuries they will incur. Although many case series have been published of IED
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injured patients,5,6,11 there is no prospectively collected definitive description of
what the injury pattern of the IED casualty is. The International Committee of the
Red Cross (ICRC) has established the injury pattern of the conventional
antipersonnel landmine.12 That work helped with the medical justification for the
eventual banning of land mines by 162 countries with the Ottawa Treaty in 1999.13
In order to ensure that physicians and surgeons are adequately prepared to treat
IED victims, this injury pattern must be described. In order that protective
equipment for our soldiers can be appropriately developed this injury pattern must
be described. Moreover, as a society in order to judge how we view the use of these
weapons, this injury pattern must be described. To provide a definitive description
of the injury pattern of the antipersonnel IED 100 consecutive casualties of this
weapon had their injuries recorded and described.

In order to implement the lessons learned from treating vascular trauma in
Afghanistan, as well as to know how to apply the data obtained from American
prospective registries we must understand the Canadian incidence and description
of vascular trauma as well as what our current practice patterns are. Who treats
vascular trauma in Canada? What injuries do they encounter and how do they treat
them? The differences in the mechanism of injury, as well as the trauma system
receiving the patient, may be important in determining what changes in practice
Canadian trauma systems should adopt. Given that Canadian trauma patients are
less likely to be injured by an IED or an assault rifle, how should we use the
information gained from wartime experiences? How does Canadian vascular
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trauma differ from that found in Afghanistan or the United States? To answer this
question, we conducted a retrospective cohort study evaluating all patients with
traumatic vascular injuries over a five year period at London Health Sciences Center
(LHSC), a Canadian level 1 trauma center.

With the advent of Tactical Combat Casualty Care (TCCC) and personal protective
equipment (PPE) more soldiers are being treated for, and surviving, potentially
preventable causes of death on the battlefield.14 However, IEDs can cause junctional
vascular injury and non-compressible torso hemorrhage not amenable to tourniquet
application of TCCC techniques.15 This has caused an interest in Resuscitative
Endovascular Balloon Occlusion of the Aorta (REBOA) with the publication of a Joint
Trauma System Clinical Practice Guideline for the use of REBOA16 . However many
REBOA techniques require two meter endovascular wires and 12 French (Fr)
sheathes that preclude this technique from being adopted in a forward medical
environment. Where REBOA portends great theoretical advantage is in the
evacuation of combat casualties from the point of injury to surgical care. Morrison et
al.’s analysis of the UK joint trauma registry over a ten-year period identified 174
deaths that had indications for REBOA. One hundred forty-five of these patients died
before reaching hospital (83%), with a mean time to death of 75 minutes. The
authors suggested that REBOA could act as en route hemorrhage control to get these
casualties to a surgeon; as many as 18% of modern combat casualties may benefit
from REBOA treatment 17. We have designed a novel device that does not require
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long endovascular wires and would be more amenable to insertion into injured
junctional vessels.

In this thesis, the injury patter of the antipersonnel IED (AP-IED) has been
described. A Canadian Level I trauma centre cohort of vascular trauma patients has
been described to help guide implementation of the lessons learned from treating
combat vascular trauma patients and American registries. Finally, a novel device to
treating the junctional and non-compressible vascular injures has been developed
and tested. Given the change in the way solders are injured in combat and the
significance this has on the type of injury being treated, the first aim of this study is
to determine the combat injury pattern caused by IED versus previous bullet or
APM casualties. Secondly, if the type of injury has changed, then both the training to
deal with this trauma needs to be characterized and suitability of interventional
devices needs to be explored. The latter aim will be addressed by defining how
Canadian Level I trauma centres deal with vascular injuries and proposing a novel
device to treat non-compressible vascular injuries in combat situations or local
communities. This current body of work further characterizes combat vascular
trauma and proposes an innovative treatment option. In this thesis, combat vascular
trauma has been taken from characterization to innovation.
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CHAPTER 2: INJURY PROFILE SUFFERED BY TARGETS OF THE
ANTIPERSONNEL IMPROVISED EXPLOSIVE DEVICE
2.1 INTRODUCTION
Antipersonnel mines (APM) came into widespread use in the Second World War.
Originally they were used to protect anti-tank mines, but then went on to become a
weapon system in and of themselves. They were designed to injure but not kill, in
order to remove a target from combat and to increase the logistical burden of caring
for the casualty. These weapons are typically buried and left for the target to trigger.
The weapon is indiscriminate because non-combatants such as children and
civilians may detonate them. They are also frequently left buried and active after
fighting in that region, or the conflict itself, has ended. Following a public relations
campaign that highlighted the indiscriminate injuries caused by APMs, 162
countries signed the 1999 Ottawa treaty ceasing their production and use.1 An
important basis of that campaign was the clinical description of APM related injuries
by Robin Coupland and Adriaan Korver for the International Committee of the Red
Cross (ICRC).2 Three patterns of injury were found among 754 victims treated at
two ICRC hospitals following wounding by blast or fragmentation mines. In pattern
1 injuries, the victim triggers a blast mine by stepping on it and suffers the full effect
of the explosion. In pattern 2 injuries, victims are farther away from the centre of
the explosion, whether it is a blast or fragmentation mine, and suffer wounds from
fragments. Pattern 3 injuries are caused by handling the mine (blast or
fragmentation), resulting in severe injuries to the hands and possibly the face and
chest. Pattern 1 victims suffer one or more traumatic amputations of the lower limb,
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whereas pattern 2 victims have fragment wounds scattered over the body. Pattern 2
victims may have fragment injuries of the lower limbs but the damage is not severe
enough to cause traumatic amputation.

This distinguishing feature of a traumatic amputation between pattern 1 and
pattern 2 injuries was confirmed in a later report of 4616 APM victims which
presented further evidence of the severity of injury particularly to the limbs.3 Of
1077 (23%) pattern 1 victims, 606 (56%) had below knee amputation (BKA), 26
(2%) bilateral BKA, 349 (32%) unilateral above the knee amputations (AKA), 57
(5%) bilateral AKA, and 39 (4%) a combination of AKA and BKA.3 Their description
of the typical pattern 1 injury profile caused by an APM, which has been confirmed
by other studies, is of a traumatic amputation of the foot or leg with scattered
penetrating injuries elsewhere. 2-5

The improvised explosive device (IED) is increasingly used in modern conflicts
including Afghanistan.6,7 The majority of these weapons have been directed against
pedestrian individuals in a similar fashion to APM.8,9 As with APM, injuries suffered
by victims of the anti-personnel IED (AP-IED) depend on whether they were the
target of the explosive device or at some distance from the centre of the explosion. It
does not depend on the manufacture of the explosive device, industrial as in APM
versus improvised as in AP-IED. Indeed elements of conventional explosives may be
used to construct an AP-IED. The blast injury depends on the energy transferred by
the explosion to the victim. However it was our impression that pattern 1 injuries
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caused by AP-IED were significantly worse than those reported for APM.2 The
purpose of this paper is to describe the profile of pattern 1 injury suffered by the
target of the AP-IED compared to the target of APM.
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2.2 METHODS
The cohort of patients under study was defined as those pedestrian victims of an APIED who suffered a traumatic amputation. In order to be included in the study,
casualties were required to have been reported by the first responder as being the
dismounted (pedestrian) victim of an IED explosion and to have suffered a traumatic
amputation. Casualties that were non-pedestrian (i.e. in a vehicle) or whose
situation was unknown were excluded. The study was designed to describe the
injuries suffered by 100 consecutive targets of AP-IED attacks who presented to the
North Atlantic Treaty Organization Role 3 Multinational Medical Unit (R3-MMU) in
Kandahar Air Field (KAF). The hospital received casualties from the point of injury
or via a forward treatment centre.10 A R3-MMU is the highest level of in-theatre
medical care and would be equivalent to a civilian level-II trauma centre, as defined
by the American College of Surgeons Committee On Trauma. A specifically
designated trauma nurse (M.D.), and attending surgeons (J.T., V.M.) prospectively
collected data for each patient. Data was collected between January 2010 and July
2011, or until data from 100 victims had been obtained. Data collected included:
nationality, age, gender, mortality status, specific injuries, and imaging results. The
level of traumatic amputation, the level of soft tissue injury, the fracture pattern
(including pelvic fractures) as well as perineal and gluteal injuries were specifically
recorded. Generally, coalition patients were transferred after damage control
surgery, whereas local patients also received definitive care at the R3-MMU. Data
were collected until the time of first discharge from the hospital. In order to
minimize bias, patients were included sequentially as a consecutive series with a

15
predefined definition of AP-IED target. The R3-MMU was the only surgical facility in
the region and would receive all AP-IED victims for care. Patient level data is
reported identifying the injuries of each of the 100 victims. The paediatric victims
are also presented separately. The data collection was complete with injury data
captured for all 100 victims. Categorical data was analysed using the chi-square test.
AP-IED data was compared to previously published APM data2. This study was
approved by the commander of the R3-MMU KAF and by the Research Ethics Board
of the University of Western Ontario (REB # 104124).

2.3 RESULTS
One hundred consecutive casualties with amputations from AP-IEDs were identified
and their injuries were described. All of the patients were male. The mean, and
median, age of the victims was 25 years. The age range was from ages 6 to 44 years.
There were 9 patients under the age of 18 (Figure 2.1). Twenty-seven patients were
Afghan local nationals and 61 were coalition soldiers (USA, Canada, UK); there were
12 victims whose nationality was not captured (Table 2.1). Eleven patients were
dead upon arrival and another 8 died of their wounds in the hospital, giving a 19%
casualty fatality rate. Gender, injury pattern, and age or approximate age, was
recorded for all victims.

16
Figure 2.1 Victim ages
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Table 2.1 Victim characteristics
Characteristic
Number of patients
Age, mean (SD)
Median
Range

100
25 (6.8) yrs
25 yrs
6 – 44 yrs

Male
Female

100
0

Nationality
Afghan

27

Coalition
American
Canadian
UK

61
49
8
4

Not specified

12

Mortality
Killed in Action
Died of wounds

SD = standard deviation

19
11
8
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AP-IED victims were more likely than a similar cohort of APM victims to suffer
multiple amputations (70.0% vs. 10.4%; p<0.001) or genital injury (26.0% vs.
13.4%; p=0.007). Seventy victims (70%) sustained multiple amputations: 5 patients
suffered quadruple amputations, 27 had triple amputations, and 38 victims had
double amputations (Figure 2.2). Two victims had hip disarticulations, 41 had at
least one AKA, and 56 had at least one BKA (including through knee and through
ankle amputations). Sixty-five victims had bilateral lower extremity amputations
and 37 had at least one upper extremity amputation (at the level of the hand or
higher) (Table 2.2). Pelvic fractures were present in 21 victims, all but one of whom
had multiple amputations. Forty-six patients had perineal and gluteal injuries; these
included 8 anorectal injuries, 8 penile injuries, and 26 scrotal injuries including 10
orchiectomies. There were 13 facial injuries, 9 skull fractures and 3 traumatic brain
injuries. Eye injuries were found in 11 patients, none of whom were wearing eye
protection. Of the 9 paediatric patients, 3 had triple amputations and 5 had double
amputations. There was one pelvic fracture and two perineal injuries among the
paediatric victims (Table 2.3). Pelvic fracture was more likely if the victim had
multiple amputations (28.6% vs. 3.3%; p=0.005) or had a perineal or gluteal injury
(32.6% vs. 11.1%; p=0.009). Those victims with multiple amputations also had more
perineal and gluteal injuries (52.9% vs. 30%; p=0.036) and a higher mortality
(24.3% vs. 6.7%; p=0.039).
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Figure 2.2: Number of amputations per victim
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Figure 2.3

X-ray taken for placement of a pelvic external fixator showing: disruption of pelvic
ring by the force of an anti-personnel improvised explosive device; combat gauze
packing a severe perineal injury; silica laden soil injection by the explosion.
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Table 2.2 Distribution of amputations
Amputation Type

Overall

Pelvic
Fracture

Perineal Killed
, Gluteal, in
Genital
Action
Injury

Died of
Wounds

Casualty
Fatality
Rate

HipDis/TKA/UEA
HipDis/AKA/AKA/UEA/UEA
AKA/AKA/UEA
AKA/AKA
AKA/BKA/UEA
AKA/TKA/UEA
AKA/BKA
AKA/TKA
AKA/UEA/UEA
AKA/UEA
AKA/TAA
AKA/BKA/BKA/UEA/UEA
BKA/BKA/UEA
BKA/TKA/UEA
BKA/BKA
BKA/UEA
BKA/TKA
BKA/TKA/TKA/UEA
TKA/TKA
TKA/TAA/UEA
TAA/UEA/-

1
1
4
7
8
2
1
7
7
1
1
1
2
1
13
1
9
2
1
22
1
1
1
1
3
1

0
0
0
3
2
1
1
1
4
0
0
0
0
0
4
0
3
0
0
1
1
0
0
0
0
0

0
0
3
6
4
0
0
5
6
0
0
0
0
0
6
1
5
0
0
9
1
0
0
0
0
0

1
1
0
0
1
1
1
0
0
0
0
0
0
1
2
0
0
0
0
0
0
0
0
0
0
0

1/1
1/1
0/4
0/7
3/8
2/2
1/1
0/7
0/7
0/1
0/1
0/1
0/2
1/1
6/13
0/1
2/9
0/2
1/1
1/22
0/1
0/1
0/1
0/1
0/3
0/1

0
0
0
0
2
1
0
0
0
0
0
0
0
0
4
0
2
0
1
1
0
0
0
0
0
0

HipDis, hip disarticulation; AKA, above knee amputation; BKA, below knee amputation;
TKA, though knee amputation, TAA, though ankle amputation; UEA, upper extremity
amputation, which includes above elbow, below elbow and hand amputations.
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Table 2.3 Distribution of paediatric amputations
Age (Years)

Amputation Type

Pelvic
Fracture

Perineal, Disposition
Gluteal,
Genital
Injury

16
14
14
11
10
10
10
10
6

AKA/BKA
AKA/AKA
AKA/UEA/UEA
UEA/TKA/AKA
BKA/BKA/UEA
UEA/TAA
BKA/AKA
BKA/BKA
UEA

No
No
No
Yes
No
No
No
No
No

No
Yes
No
No
No
No
Yes
No
No

Survived
DOW
Survived
DOW
KIA
Survived
Survived
KIA
Survived

Therefore, the typical injury profile suffered by targeted victims of AP-IEDs
included: bilateral lower extremity amputations (often above the knee); mangling or
amputation of an upper extremity; extensive soft tissue injury with deep
contamination by soil, extending into gluteal and perineal regions; pelvic ring
disruption and genital mutilation.
2.4 DISCUSSION
The mechanism of injury is the same for all anti-personnel explosive devices. The
severity of injury depends upon the energy transferred by the explosion to the
victim. There is nothing inherently different between the APM and the AP-IED.
Indeed the AP-IED might be considered a subset of APM. However, the comparison
in this study is between the conventional blast APM, industrially manufactured for
national armies and the AP-IED, that were manufactured locally from available
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materials and used in the recent conflict in Afghanistan. Coupland and Korver
believed they were dealing with the former device.2,3,4 In a textbook reflecting on the
Russian experience in Afghanistan, Bruysov and colleagues illustrated the
mechanism of injury from the conventional blast APM in a series of experiments
using rapid sequence photography which confirmed Coupland and Korver's
description of a foot amputation with scattered penetrating injuries elsewhere.11
The AP-IED, sometimes portrayed as a primitive or crude weapon crafted from
locally available resources because of a lack of access to conventional weapons, has
evolved with use in different conflicts. From rudimentary devices of nails in wooden
boxes used in Cambodia and Columbia, AP-IEDs used in recent conflicts are better
directed and more destructive. The injury profile from the modern AP-IED is far
worse than originally described for conventional blast APMs. Whereas the blast APM
typically results in a unilateral lower limb amputation, the modern AP-IED causes
bilateral high amputation of the lower extremities. Triple amputations were not
seen with APM but occurred in 27% of victims of AP-IEDs. Severe perineal and
gluteal injury with soft tissue contamination with soil was commonly present in the
victims of the AP-IED but is not seen among the ICRC experience with APM injured
patients. 2 The energy transfer endured by targeted victims of AP-IEDs must be far
greater than that caused by APMs. A measure of the force is the fact that it is
sufficiently powerful to disrupt the pelvic ring in one fifth of the patients (Figure
2.3).
It is not the purpose of this paper to undermine the abhorrence of injuries caused by
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conventional APMs, which are often devastating and ruin lives. Both the APM and
AP-IED injure indiscriminately. In this series, almost one in ten victims of AP-IEDs
was a child, a tragic feature in common with APMs. Even more disconcerting is the
frequency with which children suffer the severest injuries from the powerful
explosive force of the AP-IED: 89% suffered multiple amputations and 33% lost
three limbs.
The AP-IED victims wore different types of personal protective equipment (PPE) or
none at all. Coalition soldiers wore PPE including helmets, body armour, and antiballistic eyewear. Each nation issued its own style and brand of PPE. Local Afghan
soldiers often used helmets but their use of body armour was more inconsistent and
they almost never used ballistic eyewear. Civilian casualties were not wearing any
PPE. This heterogeneity of PPE use in our sample may have affected the pattern of
injury characterized in this study but the sample size was insufficient to determine
accurately the injury preventative role of PPE. We felt there was a lower than
expected rate of abdominal, thoracic and eye injuries in victims wearing PPE. We
also felt that the design purpose of PPE, to prevent fragment injury, was confirmed
in patients with pattern 2 injuries who are not included in this study.
It is possible that we have magnified the severity of the injury pattern by
concentrating our focus upon patients that met our definition of being targeted by
the AP-IED, that is having sustained at least one limb amputation. It is also possible
that if a casualty was injured by an unexploded ordinance or classical land mine but
reported by first responders to have been injured by an AP-IED they may have been
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erroneously included. However our findings are in keeping with other descriptions
of IED injuries in the literature. Jacobs et al. classified the limb injury pattern of 103
consecutive casualties of IEDs treated at a UK Role 3 facility in Helmand Province,
Afghanistan.12 They included victims who did not have amputation of a limb. They
found 76 victims suffered significant bilateral lower limb injuries, with 50 who
required bilateral lower limb amputation. Thirty-three victims suffered genital or
perineal injury, 9 sustained pelvic ring disruption, and 40 sustained significant
upper limb injury. They found that all pelvic fractures and 80% of genital injuries
were sustained among casualties with bilateral lower limb amputations. A
retrospective review of the UK Joint Theatre Trauma Registry examined UK services
personnel who were casualties of IEDs in Afghanistan, who sustained lower
extremity amputations between January 2007 and December 2010.13 This registry
includes post-mortem reports of soldiers who were killed and never received
hospital care. The registry is restricted to UK service members and contains no local
nationals or civilian injuries. They examined 656 IED victims with 138 killed in
action (21%) and 31 who died of their wounds (4.7%) resulting in a 25.9% casualty
fatality rate. Of the 169 victims who sustained a traumatic lower extremity
amputation, 69 were killed in action (40.8%) and 31 died of their wounds (18.3%).
They found that the level of amputation was inversely correlated with survival with
only two survivors from hindquarter amputation out of 39 patients with this level of
injury. Another retrospective review of the UK Military Trauma Registry focused on
soldiers from Afghanistan with bilateral leg amputation.8 They examined 43
casualties with at least two amputations; 80% of these were from AP-IEDs with the
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other 20% being from anti-vehicle-IEDs. The most common bilateral amputation
was a bilateral AKA (58%), and 20% of victims suffered triple amputation. 14% of
victims sustained open pelvic fractures and 44% suffered perineal or genital injury.
No victims survived the loss of all four limbs.
The soft tissue injury is a particularly difficult problem encountered by those caring
for victims of AP-IEDs. The directed explosion forces soil up along soft tissue planes
far above the point of entry. This may worsen the level of eventual amputation and it
condemns the victim to multiple operations to remove the contamination. Even still,
it may leave the victim at the mercy of unusual antibiotic resistant soil organisms
such as Acinetobacter baumannii.14
Knowing the pattern of injury helps responders tailor care. As Jacobs and colleagues
have suggested, first responders should apply tourniquets bilaterally even if the
victim is not bleeding, as haemorrhage is likely to start once resuscitation restores
intravascular volume.12 While current protocols require medics to apply a neck
collar to all victims of IEDs, spinal injury is rare in AP-IED victims despite the
magnitude of the force.9 On the other hand, we recommend that all AP-IED victims
with perineal injuries or multiple amputations have pelvic binders placed by the
first responders, as both are associated with pelvic fracture. This may reduce the
large amount of blood that may be lost silently with pelvic disruption. Multiple
surgical teams have to work simultaneously to rescue these patients. Surgeons have
to be adept at dealing with pelvic and gluteal bleeding, sometimes by pre-peritoneal
packing and by ligating the internal iliac artery. Rehabilitation requires mobilization
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on temporary lower limb prostheses despite injured upper limbs. Finally, victims of
this severe injury pattern need life-long support because disabilities may become
more pronounced as the capacity to compensate fades with age.
In collecting information on 100 consecutive patients, we hope to have described a
generalizable result. Due to the nature of the conflict and the local culture, all of the
patients examined were male. While we would expect the severity of the injury
pattern to be generalizable to females, we cannot explicitly determine the effect of
the modern AP-IED on the female pelvis and perineum.
The use of conventional APM has decreased in the last 20 years since the campaign
to prohibit their use. Pattern 1 injuries seen in recent conflicts are far more often
from AP-IEDs than conventional APMs. ICRC includes AP-IEDs in its definition of
APM if the victim triggers the weapon. The injury profile described in this report is
illustrated in the recent edition of its textbook on war surgery.15 Despite the huge
force endured by the targeted victim of the AP-IED, the casualty fatality rate that we
observed was 19%. This rate is an underestimate, as some casualties who were
killed at the site of the AP-IED may not have been brought to our facility and others
may have died as a result of injuries after transfer or discharge. Reports regarding
APM are also affected by this problem. The observed mortality rate with AP-IED is of
the same order as that elsewhere.15 The injury pattern suffered by the target of the
AP-IED is markedly worse than that of conventional APM. Pelvic binders and
tourniquets should be applied at the point of injury to patients with multiple
amputations or perineal injuries. The AP-IED causes more severe injury than APM. It
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is a weapon which of its nature causes superfluous injury and unnecessary suffering.
Just as the reports by Coupland and Korver provided the medical evidence upon
which the prohibition of conventional APM was based, it is hoped that reports
regarding the pattern of injury caused by the modern AP-IED will result in an
abhorrence of this weapon and those who use it.
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CHAPTER 3: INCIDENCE AND MANAGEMENT OF VASCULAR TRAUMA: A
CANADIAN EXPERIENCE
3.1 Introduction
In the past decade there has been a shift in the therapies and philosophies
associated with treating vascular trauma. Damage control resuscitation and the use
of vascular shunting and tourniquets have become more emphasized 1-4. Much of
this evolution has been as a result of findings captured in trauma registries in Iraq
and Afghanistan 5-7. Novel technologies have been introduced to temporize the
exsanguinating vascular trauma patient, including the resuscitative endovascular
balloon occlusion of the aorta for hemorrhage control (REBOA)8.

In order to describe the state of vascular trauma therapy in the United States, as
well as to be able to capture long-term outcomes from vascular trauma intervention,
the American Association for the Surgery of Trauma (AAST) developed a
Prospective Observational Vascular Injury Treatment Registry (PROOVIT) 9. This
registry, which is comprised of 14 Level I and Level II trauma centers, has published
their first year’s findings. An American retrospective evaluation of vascular trauma,
and in particular intravascular shunt use, has also recently been published 10. This
paper described shunt usage, rates of limb salvage and mortality, shunt thrombosis,
length of time shunts were in place, and the operation at definitive repair.

The epidemiology of trauma is very different in Canada than in the United States.
Since penetrating trauma is much less prevalent in Canada, it would stand to reason
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that the epidemiology of traumatic vascular injuries would likewise have a different
distribution. Moreover, vascular trauma may be more likely to be managed by a
vascular surgeon in Canada than a trauma surgeon as compared to the United
States, where many trauma centre have in-house trauma surgeons 24 hours a day.

The aim of this study was to conduct a retrospective review of vascular trauma at
London Health Sciences Center (LHSC), a Canadian level I trauma center, over a fiveyear period. Any named vessel injury of the extremities, torso, or neck was captured,
allowing for a description of the epidemiology of vascular trauma at this Canadian
centre and an understanding of the present usage of damage control vascular
surgery, specifically the use of shunts, tourniquets and aortic blockers. This
retrospective study will provide a Canadian context through which the American
prospective data of the PROOVIT registry can be interpreted. It will allow for an
understanding of the present Canadian incidence of named vessel injury as well as
our adoption of damage control techniques. This will help guide efforts in trauma
system management, surgical education, and research and innovation.
3.2 Methods
The medical records and trauma registry of London Health Sciences Centre (LHSC)
were searched for all patients with the International Statistical Classification of
Diseases and Related Health Problems 10th revision (ICD -10) codes for vascular
injury. All adult trauma patients (18 years of age or older) with injuries to named
arterial or venous vessels in the legs, arms and torso, and neck from 1 January 201131 December 2015 were included. Data was collected using the Research Electronic
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Data Capture (REDCap) secure data platform. Vessel injuries in the head were not
included because of significant difference in the treatment and outcomes of these
types of injuries. This five-year period was selected because it is sufficiently long to
capture a representative sample of vascular trauma, and it is sufficiently modern to
capture the new changes in vascular trauma practice, which may have occurred
since the lessons learned from the conflicts in Afghanistan and Iraq.

The primary outcome of this study is the description of the incidence of injury to
named vessels in the London trauma patient population. Further descriptive data
such as demographics, baseline co-morbidities, injury type, injury mechanism,
injury severity on presentation, modality used to characterize and identify the
injury, type of injury encountered, and technique of repair, whether a tourniquet,
intravascular shunt or occlusion device was used, was also be captured. Further
information, such as if the patient presented to a trauma centre or was transferred
from a peripheral hospital, if the surgeon was a trauma or vascular surgeon, if a
temporary versus definitive repair was done, type of definitive repair, length of time
the shunt was in place if used, occurrence of shunt thrombosis, fasciotomy rate,
occurrence of compartment syndrome limb salvage and requirement for
amputation, and mortality during hospital stay, was also collected. This information
was obtained from the trauma registries, initial operative report, and electronic
medical record.
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Continuous parameters are expressed as means with standard deviations and
medians with interquartile ranges, as appropriate. Categorical data are expressed as
proportions. SPSS Version 23 (IBM Inc., 2011) was used for data analysis. The
Research Ethics Board of the University Western Ontario approved this study (REB
# 107912).

3.3 RESULTS
From 1 January 2011 to 31 December 2015, 127 patients presented with named
vessel injuries as a result of trauma. 89 patients were male (70.1%) and the mean
age was 40.8 years. Blunt mechanism accounted for 61.4% of injuries and the most
common mechanism of injury was motor vehicle crash (33.1%). The most common
penetrating mechanism was stabbing which accounted for 18.1%. The mean Injury
Severity Score (ISS) score was 21.8 with 63.3% of patients having an ISS of 15 or
greater. Hypotension was present in 11.3% of patients on admission. The modality
most commonly used to identify injury was Computed Tomography Angiogram
(CTA) (58.3%) with operative exploration being the second most common (35.4%)
(Table 3.1).

A wide range of vascular injuries was identified, with the most common being the
descending thoracic aorta (14.3%) (Table 3.2). Non-operative management was
most common (28.3%) followed by open surgery (48.8%) and endovascular repair
(12.3%). Among those trauma vascular patients who received interventions, open
surgery was the most common (77.9%). Endovascular techniques were commonly
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used for aortic injuries (58.3%) (Table 3.4). Only one case used a damage control
approach with the vast majority of practitioners opting for initial definitive repair.
There was no temporary intravascular shunt use. The most common repair was
with autologous vein (16.7%) and primary repair and ligation were each used
15.9% of the time. Fasciotomies were performed 12 times, 9 of which were
prophylactic. 12 patients died in hospital with three dying before attempted
vascular management. Overall mortality was 9.4%. There were 3 amputations, 4
surgical site infections and 4 strokes (Table 3.3).
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Table 3.1 Epidemiology of vascular trauma patients
Total number of patients with named vessel
injury
Demographics
Male, n (%)
Age, mean (SD), years
BMI, mean (SD)
Transferred from outside hospital, n (%)
Comorbidities, n (%)
Coronary artery disease
Diabetes mellitus
Fully anticoagulated
Antiplatelet use
Bleeding disorder
Dialysis
Cirrhosis
Injury type, n (%)
Blunt
Penetrating
Mixed
Mechanism, n (%)
Motor vehicle crash
Other or unknown
Stabbing
Fall
Industrial accident
Gunshot
Pedestrian vs auto
Athletic injury
Presentation
ISS, mean (SD)
ISS ≥15, n (%)
Head AIS score ≥3, n (%)
Abdominal AIS score ≥3, n (%)
Chest AIS score ≥3, n (%)
Extremity AIS score ≥3, n (%)
Admission SBP, mean (SD)
Hypotension (SBP ≤90) on arrival, n (%)
GCS score ≤8 in arrival, n (%)
Admission hemoglobin, mean (SD)
Admission pH, mean (SD)
Admission lactate, mean (SD)
Platelets, mean (SD)
Modality used to identify/characterize injury,
n (%)
Operative exploration
CTA
Duplex ultrasound
Traditional Angiography
MRA
Transesophageal echo
Type of injury identified, n (%)
Transected
Occlusion
Partial transection or flow limiting defect
Pseudoaneurysm

London
127

PROOVIT
542

89 (70.1)
40.8 (18.3)
26.5 (5.6)
64 (50.4)

382 (70.5)
37.7 (17.4)

2 (1.6)
4 (3.1)
1 (0.8)
3 (2.4)
1 (0.8)
0 (0)
1 (0.8)

11 (2.0)
2 (0.4)
9 (1.7)

78 (61.4)
47 (37)
2 (1.6)

255 (47.0)
198 (36.5)
5 (0.9)

42 (33.1)
35 (27.6)
23 (18.1)
9 (7.1)
8 (6.3)
5 (3.9)
2 (1.6)
3 (2.4)

152 (28.0)
134 (24.7)
39 (7.2)
39 (7.2)
17 (3.1)
129 (23.8)
30 (5.5)
2 (0.4)

21.8 (13.8)
81 (63.3)
23 (18.1)
36 (28.3)
49 (38.2)
62 (48.8)
125.5 (29.3)
12 (11.3)
15 (14.2)
126 (20.0)
7.27 (0.11)
3.5 (2.7)
214.9 (71.7)

20.7 (14.7)
174 (32.1)
65 (12.0)
78 (14.4)
66 (12.2)
154 (28.4)
120 (34)
64 (11.8)
97 (17.9)
12.3 (2.2)
7.26 (0.15)
4.4 (4.2)
227 (77)

45 (35.4)
74 (58.3)
0 (0)
5 (3.9)
2 (1.6)
1 (0.8)

161 (29.7)
215 (39.6)
17 (3.1)
62 (11.4)

65 (51.2)
13 (10.2)
45 (35.4)
11 (8.7)

136 (25.1)
96 (17.7)
138 (25.5)
49 (9.0)
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Table 3.2 Distribution of vascular injuries
Named Vessel injured
Neck, n(%)
Common carotid
Internal carotid
External carotid
Vertebral artery
Superior thyroid artery
Facial artery
Internal jugular vein
External jugular vein
Thorax, n (%)
Aortic arch
Descending thoracic aorta
Innominate artery
Subclavian artery
Coronary artery
Internal mammary artery
Intercostal artery
Inferior vena cava
Innominate vein
Subclavian vein
Abdomen/Pelvis, n (%)
Abdominal aorta
Common iliac
External iliac
Internal iliac
Celiac Artery
Common hepatic artery
Superior mesenteric artery
Renal artery
Splenic artery
Left gastric artery
Middle colic artery
Internal pudendal artery
Superior gluteal artery
Inferior gluteal artery
Obterator artery
Lateral femoral circumflex artery
Retro Hepatic IVC
Infra-renal IVC
Iliac vein
Portal vein
Renal vein
Splenic vein
Gonadal vein
Upper extremity, n (%)
Axillary artery
Brachial artery
Radial artery
Ulnar artery
Posterior circumflex humeral artery
Princeps pollicis
Axillary vein
Basilic vein
Brachial vein
Lower extremity, n (%)
Common femoral artery
Superficial femoral artery
Deep femoral artery
Popliteal artery
Anterior tibial artery
Posterior tibial artery
Peroneal artery
Common femoral vein
Superficial femoral vein
Deep femoral vein
Popliteal vein
Great saphenous vein
Posterior tibial vein

Total injuries (n = 147)
30 (20.4)
1 (0.7)
6 (4.1)
0 (0)
17 (11.6)
1 (0.7)
1 (0.7)
2 (1.4)
2 (1.4)
30 (20.4)
3 (2.0)
21 (14.3)
1 (0.7)
1 (0.7)
1 (0.7)
1 (0.7)
1 (0.7)
1 (0.7)
0 (0)
0 (0)
29 (19.7)
3 (2.0)
1 (0.7)
2 (1.4)
1 (0.7)
1 (0.7)
0 (0)
0 (0)
3 (2.0)
0 (0)
1 (0.7)
1 (0.7)
4 (2.7)
2 (1.4)
1 (0.7)
2 (1.4)
1 (0.7)
0 (0)
3 (2.0)
0 (0)
0 (0)
2 (1.4)
0 (0)
2 (1.4)
36 (24.5)
3 (2.0)
13 (8.8)
7 (4.8)
7 (4.8)
1 (0.7)
1 (0.7)
0 (0)
2 (1.4)
2 (1.4)
22 (15.0)
0 (0)
3 (2.0)
0 (0)
7 (4.8)
4 (2.7)
3 (2.0)
0 (0)
0 (0)
2 (1.4)
0 (0)
2 (1.4)
0 (0)
1 (0.7)
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3.3 Management and complications of vascular injuries
Management n(%)
Non-operative management
Endovascular repair
Initial non-definitive open surgery
Definitive open surgery
Damage control technique
Fasciotomy
Shunt used
Ligation
Primary repair
Autologous repair
Synthetic graft
Died before vascular management
Embolization
Complications
In hospital mortality
Amputation
Compartment syndrome
Shunt thrombosis
Dislodged shunt
Surgical site infection
Stroke

London
39 (28.3)
17 (12.3)
1 (0.7)
59 (42.8)
1 (0.7)
12 (8.7)
0 (0)
22 (15.9)
22 (15.9)
23 (16.7)
3 (2.2)
3 (2.2)
9 (6.5)

PROOVIT
276 (50.9)
40 (7.4)
165 (37.8)
126 (23.2)
57 (10.5)

12 (9.4)
3 (2.4)
3 (2.4)
0
0
4 (3.1)
4 (3.1)

48/376 (12.7)
18 (3.3)

14 (2.6)
31 (5.7)
37 (6.8)
61 (11.3)
7 (1.3)

16 (3.0)
6 (1.1)
12 (2.2)
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3.4 Management of specific arterial injuries
Nonoperative
management
Neck, n (%)
Common carotid
Internal carotid
External carotid
Vertebral artery
Thorax, n (%)
Aortic arch
Descending thoracic aorta
Innominate artery
Subclavian artery
Abdominal/Pelvis, n (%)
Abdominal aorta
Common, external, or
internal iliac arteries
Celiac artery
Renal artery
Upper extremity, n (%)
Axillary artery
Brachial artery
Radial artery
Ulnar artery
Lower extremity, n (%)
Common, superficial or
deep femoral artery
Popliteal artery
Anterior tibial artery
Posterior tibial artery
Peroneal artery

Endovascular
repair

Open Surgery

Died before
repair

1/1 (100)
6/6 (100)
0
17/17 (100)

0/1
0/1
0
0/17

0/1
0/1
0
0/17

0/1
0/1
0
0/17

1/3 (33.3)
7/21 (33.3)
1/1 (100)
0/1

1/3 (33.3)
13/21 (61.9)
0/1
1/1 (100)

1/3 (33.3)
1/21 (4.8)
0/1
0/1

0/1
0/1
0/1
0/1

2/3 (66.6)
0/4

0
0/4

1/3 (33.3)
1/4 (25)

0/1
3/4 (75)

1/1 (100)
2/3 (66.6)

0/1
0/3

0/1
1/3 (33.3)

0/1
0/3

1/3 (33.3)
0/13
0/7
0/7

1/3 (33.3)
0/13
0/7
0/7

1/3 (33.3)
13/13 (100)
7/7 (100)
7/7 (100)

0/3
0/13
0/7
0/7

0/3

2/3 (66.6)

1/3 (33.3)

0/3

0/7
1/4 (25)
0/3
0

0/7
0/4
0/3
0

7/7 (100)
3/4 (75)
3/3 (100)
0

0/7
0/4
0/3
0
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There were 49 peripheral arterial injuries. Prehospital tourniquets were used on 6
occasions (12.2%) with only one having a tourniquet time recorded (4.5 hours).
Tourniquets were applied in the trauma bay 4 times. Resuscitative thoracotomies
were performed three times, on two occasions by a general surgeon and once by a
trauma surgeon. No REBOA was used (Table 3.5).

Vascular surgeons managed the majority of the vascular injuries (n = 77), with
plastic surgeons (n = 11), interventional radiologists (n = 11), and general surgeons
being the next most common (n = 9) (Table 3.6). All vascular injuries managed by
plastic surgery were in the upper extremity. Interventional radiology deployed
endovascular stents to the subclavian artery and the axillary artery. All other
interventional radiology interventions were embolizations to the internal pudendal,
superior and inferior gluteal, obturator, and posterior circumflex of the humeral
arteries. Neurology managed two vertebral artery injuries.

3.5 Tourniquets, fasciotomies, and resuscitative techniques (n)

Peripheral artery injuries
Prehospital tourniquet use
Trauma bay tourniquet use
Fasciotomy, prophylactic
Fasciotomy therapeutic
REBOA use
Resuscitative thoracotomy
Temporary intravascular shunt use

London n (%)
49
6/49 (12.2)
4/49 (8.2)
9/49(18.4)
3/49 (6.1)
0
3
0

PROOVIT n (%)
233
47/233 (20.2)
33/233 (14.2)
19/233 (8.2)
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3.6 Discipline of physician who managed the vascular injury
Discipline managed vascular injury
General surgeon
Trauma surgeon
Vascular surgeon
Orthopedic surgeon
Thoracic surgery
Cardiac surgery
Plastic surgery
Otolaryngology
Urology
Gynecology
Neurosurgery
Interventional radiology
Neurology

Total patients (n=127)
9
3
77
2
3
2
11
3
1
1
2
11
2

3.4 DISCUSSION
In order to improve linkage of management of vascular traumatic injuries to short
and long-term outcomes, the American Prospective Observational Vascular Injury
Treatment (PROOVIT) registry was initiated 9. This registry was inspired by the
success of military vascular trauma registries in Iraq and Afghanistan 5-7. Their view
was to document the evolution of vascular care from the prehospital environment to
definitive management. Concepts such as tourniquet use, temporary intravascular
shunts and damage control principles have been used extensively in the military
setting with good success and are now being incorporated into civilian institutions
practice 1,2,11,12.

The PROOVIT registry may be very important in monitoring the effectiveness of
these damage control techniques as well as the expanding field of endovascular
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intervention for trauma. This registry captures patients from 13 American level I
Trauma Centres and one level II trauma Centre. However, the type of trauma
experienced, as well as the resources available, and training of the practitioners
providing the care and therapy may be different than what exists in Canada. While
establishing a Canadian prospective vascular trauma database is an ambitious way
to examine the Canadian experience, a faster and less costly approach is to
retrospectively examine Canadian vascular trauma and use that data as a lens
through which the American experience can be interpreted. By knowing the ways in
which the Canadian and American vascular trauma population are similar, and the
ways that they differ, the findings from the PROOVIT registry that are applicable to
Canadian practice can be identified.

The Canadian patients were of similar age (40.8 vs. 37.7) (hereafter, LHSC results
are given before those from PROOVIT) and were also predominantly male (70.1%
vs. 70.5%). The mean injury severity score between the two groups was similar (ISS
21.8 vs. ISS 20.7) with this study having a larger proportion of patients with ISS
scores above 15 (63.3% vs. 32.1%). Both groups had very similar rates of
hypotension on admission (11.3% vs. 11.8%). Canadian patients were more likely to
have suffered from a blunt mechanism of injury (61.4% vs. 47%). The most common
mechanism of blunt injury was motor vehicle crash for both populations (33.1% vs.
28.0%); however, whereas the most common penetrating mechanism in the
PROOVIT registry was gunshot (23.8%) at LHSC the most common penetrating
mechanism was stabbing (18.1%).
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The most common non-operative method of identifying vascular injury was CTA but
this modality was more common in the Canadian experience (58.3% vs. 39.6%) with
the PROOVIT patients receiving duplex ultrasound (0% vs. 3.1%) and traditional
angiography more often (3.9% vs. 11.4%). The Canadian patients were more likely
to receive operative exploration (35.4% vs. 29.7%). The most common vessel
injuries in this study was the descending thoracic aorta (14.3%) followed by the
vertebral artery (11.6%) whereas the most commonly injured vessel in the
PROOVIT registry was the internal carotid artery (11.4%). This difference may be
reflective of the greater proportion of blunt trauma in the Canadian trauma
population.

Both studies found non-operative intervention was the most common but it was
more frequent in the PROOVIT registry (28.3% vs. 50.9%). Endovascular
intervention was more popular in Canada (12.3% vs. 7.4%). This difference may be
due to the prevalence of blunt aortic injury in the Canadian group.

No patient received a temporary intravascular shunt in this study whereas 2.6% did
in PROOVIT. This study found that 12.2% of extremity arterial injuries received
prehospital tourniquets whereas 20.2% did in the PROOVIT registry. Unfortunately
the time of tourniquet application was poorly documented with only one tourniquet
time available and that being a long application of 4.5 hours. In PROOVIT 25%
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lacked documentation of tourniquet time and 40.4% of tourniquets were on for less
than one hour.

The Canadian vascular trauma population is sufficiently similar to the population of
the PROOVIT registry for the results that are accrued from the PROOVIT registry to
be of great interest. In particular endovascular techniques for trauma are being
expanded to junctional areas such as subclavian or axillary arteries13 as well as
more peripheral arteries 14. There were Canadian trauma patients receiving these
therapies, and knowing the outcomes of these interventions will be very important.
That outcomes information can be obtained from the PROOVIT registry and will
likely be applicable to the Canadian trauma population.

One way in which the Canadian and American populations likely differ is in who
repairs the vascular injury. In our study, vascular surgeons repair the majority of
vascular trauma, with only three injuries in five years being repaired by a trauma
fellowship trained surgeon. Multiple subspecialty surgeons were involved in
managing vascular injuries. This diffusion of who is responsible for vascular trauma
is likely very different from an American centre who may have an in-house trauma
surgeon managing the majority of vascular injuries. This is an important Canadian
characteristic to recognize and appreciate as findings and outcomes of vascular
trauma research are attempted to be disseminated and Canadian trauma systems
evolve and implement new techniques.
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Tourniquet use is much less frequent in Canada. Not all peripheral arteries need a
tourniquet. A distal radial transection will likely go into spasm and can safely be
controlled with direct pressure. However, military experience has shown that
tourniquet use can be safe and effective11,16. If a tourniquet is being used,
documenting when it is applied and removed is important both for an
understanding of the patient’s recovery and ischemic injury, but also to be able to
study the effect of this tool in a civilian environment. Military patients are usually
air-lifted quickly to a surgical facility meaning that tourniquets are on for only a
short time15. If civilian application times are consistently longer then the algorithm
for their use will likely differ from our military counterparts.

Commercial intravascular temporary shunts are available at LHSC and could have
been used during the study period. There have been civilian studies showing their
safe and effective use for both damage control and staged orthopedic vascular
injuries 10. The PROOVIT registry will collect further data with respect to the safety
and optimal use of this tool. This may prove to be an example of a vascular trauma
tool worthy of adoption into the Canadian armamentarium.

The vascular trauma patient in this study had similar age and injury severity to
those in the PROOVIT registry; however, was more likely to have suffered a blunt
injury and was likely treated by a vascular surgeon. No temporary intravascular
shunts were used and prehospital tourniquet use was less frequent and, when
applied, their time of occlusion was poorly captured. The PROOVIT registry may be
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of particular use to Canadian patients in tracking the outcomes of endovascular
trauma interventions as endovascular therapies were used for aortic injuries,
junctional injuries and extremity vascular injuries at this Canadian trauma center.
Hopefully with the present data the PROOVIT experience can be optimally
interpreted and lessons learned applied to a Canadian context.
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CHAPTER 4: NOVEL JUNCTIONAL VASCULAR INJURY OCCLUSION DEVICE

4.1 Introduction
Resuscitative endovascular balloon occlusion of the aorta (REBOA) is an emerging
technique used to support blood pressure and decrease hemorrhage in trauma. As it
continues to be studied and experience increases, new applications of this
technology are being proposed. The most enthusiastic supporters have suggested
REBOA as a potential pre-hospital intervention to enable the exsanguinating trauma
patient to survive until surgical intervention1. Given the injury pattern of modern
combat casualties, ultrasound-guided placement of a REBOA device in the distal
aorta may help more patients survive evacuation to surgical management. In order
for this to be feasible, a novel device needs to be developed that is not encumbered
by a long wire, is easy to use, and can manage damaged iliac and femoral vessels.

Modern conflicts have seen a shift in the type of weapons used against coalition
soldiers. In the recent Afghan war, fewer soldiers were injured with rifles and
conventional ballistic weapons than were injured by improvised explosive devices
(IED)2,3. Medically, it is most appropriate to classify these weapons by their target:
crowd attack IED (CA-IED), anti-vehicle IED (AV-IED), and the antipersonnel IED
(AP-IED)4. CA-IEDs cause injury by projectile fragments and their effect may be
magnified by enclosed spaces, AV-IED have very large explosions and cause injuries
similar to high-energy motor vehicle collisions, and AP-IEDs cause multiple
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amputations and significant pelvic and perineal injury4,5. These victims can present
the challenge of non-compressible torso hemorrhage6,7.

Combat pre-hospital medical care has simultaneously made great advancements.
With Tactical Combat Casualty Care (TCCC) and personal protective equipment
(PPE), more soldiers are being treated for, and surviving, potentially preventable
causes of death on the battlefield 8. However, there is very little a forward military
physician can offer a patient with non-compressible torso hemorrhage other than
rapid evacuation to a surgical facility. Could REBOA temporize the bleeding IED
victim for transportation to the operating room? If the correct device was available
pre-hospital combat use of the REBOA could save soldiers lives.

4.1.1 Standard REBOA technique
In 2011, Stannard et al. described the modern five-step technique of REBOA
insertion via femoral artery cannulation and defined three zones of balloon
deployment. The five steps for the REBOA procedure are: 1) arterial access and
sheath insertion, 2) balloon positioning, 3) balloon inflation, 4) balloon deflation,
and 5) sheath removal. They defined Zone I as the thoracic aorta extending from the
subclavian artery to the celiac artery, Zone II as the non-occlusion zone between the
celiac artery and renal arteries and Zone III as the infrarenal aorta to the iliac
bifurcation (Figure 4.1). Deployment of REBOA in zone I is analogous to the
hemostatic control of a resuscitative thoracotomy with cross clamping of the
thoracic aorta, which controls hemorrhage from the abdomen and pelvis and
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increases cerebral and coronary blood flow. REBOA in Zone III provides occlusion to
help control pelvic or junctional hemorrhage without causing visceral ischemia 9.
Figure 4.1 Zones of REBOA deployment

Aortic zones related to REBOA. Zone I extends from the origin of the left
subclavian artery to the celiac artery and is a potential zone of occlusion. Zone II
extends from the celiac artery to the lowest renal artery and is a a no-occlusion
zone. Zone III exists from the lowest renal artery to the aortic bifurcation. REBOA in
this zone may provide particular utility for instances of pelvic and junctional
femoral hemorrhage.
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4.1.2 REBOA in the Military
The origins of REBOA are in military medicine. Lieutenant-Colonel Carl Hughes of
the United States Army Medical Corps, used balloon aortic occlusion in two patients
in the Korean Conflict and although both died he speculated that this technique
could save lives in the future 10. Although originating in the treatment of combat
casualties, aortic balloon occlusion for hemorrhage control was first adopted in the
civilian context for the management of abdominal aortic aneurysms, 11 and it is only
in the past decade that REBOA for trauma patients has transitioned from an
experimental technique to a tool for clinical study and use 12.

Interest in REBOA re-emerged within the military context during the Afghanistan
and Iraq conflicts and military surgeons have been actively involved in its research
and development 12. The American military has published the Joint Trauma System
Clinical Practice Guideline for REBOA, identifying its use as an alternative approach
to thoracotomy in some cases, and described a role for preemptive placement in
high-risk unstable patients 13. This guideline is designed to apply in a location with
surgical capability. A REBOA data tool is used to capture the technique’s use for
study. A retrospective analysis indicated that as many as 18% of modern combat
casualties could benefit from REBOA treatment 14. This technique is less morbid
than a resuscitative thoracotomy and may have a role in the hypotensive pre-arrest
patient by increasing their blood pressure and decreasing hemorrhage before
progression to arrest and the need for resuscitative thoracotomy15. A recent
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systematic review showed that REBOA increased systolic blood pressure by a mean
of 53 mmHg (95% confidence interval 41-61 mmHg), but it did not demonstrate a
clear reduction in hemorrhage-related mortality 16. The studies comprising this
review were case series, case reports and cohort studies; as registries accrue,
prospective studies may illuminate additional circumstances showing an advantage
of the REBOA technique in treating trauma patients with difficult to control
hemorrhage.

Where REBOA portends great theoretical advantage is in facilitating the evacuation
of combat casualties from the field to definitive surgical management. Morrison et
al.’s analysis of the UK joint trauma registry over a ten-year period identified 174
deaths that met indications for REBOA. One hundred forty-five of these patients died
before reaching hospital (83%), with a mean time to death of 75 minutes. The
authors suggested that REBOA could act as en route hemorrhage control to get these
casualties to a surgeon14. This application requires that REBOA be used in a presurgical environment. Before REBOA can be implemented in battlefield operations
in a forward environment, medical leadership must make decisions regarding what
method should be used to gain arterial access, which patients this therapy would
apply to, the zone of REBOA deployment, and what training would be required for
medical officers using this therapy.
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4.1.3 Arterial Access
Arterial access is the first step in deployment of REBOA and providers currently
have the option of a formal vascular cut-down, external anatomical landmarking
with percutaneous access, or ultrasound-guided percutaneous access 9. Vascular
cut-down yields direct visualization of the target vessel, facilitating reliable
cannulation of the common femoral artery (CFA) in a pulseless or profoundly
hypotensive patient; however, it can be time consuming and requires surgical
training. Landmark percutaneous access carries increased risk of venous
cannulation, increased risk of vascular injury, and overall lower success rates 17.
Additionally, the probability of successful placement is compromised in the
extremely hypotensive or pulseless patient 16. Ultrasound-guided femoral artery
access has the advantage of making catheter placement possible in the patient with
severe hypotension without requiring a cut-down. It may increase the speed of
percutaneous access, and the ultrasound can also be used to confirm the positioning
of the balloon once it is deployed 1. In the civilian context, all three techniques are
used, with 50% gaining access by cut down, 28% by land marks and 11% by
ultrasound guidance18. For the combat casualty in a non-surgical environment,
ultrasound-guided percutaneous vascular access is the most attractive option; it
alleviates the training requirement for performing a cut-down, may still be
performed in the context of extreme hypotension, and ultrasound use is a skill
already familiar to most military physicians. An environment that could facilitate
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forward REBOA placement could be equipped with portable ultrasound, making this
approach both feasible and efficacious.

4.1.4 REBOA and evacuation
Exsanguination is the number one cause of death on the battlefield and thus
hemorrhage control must be the top priority of the provider treating the injured
soldier 19,20. REBOA has the potential to help combat casualties survive to surgery in
situations where they would otherwise die without aortic occlusion 14; however,
delaying transport of a combat casualty while attempting to perform interventions
could also be problematic and deadly. In the hands of experts, REBOA can be
deployed in six minutes18,21. We believe this represents a reasonable benchmark by
which military REBOA programs should self-evaluate. If a combat REBOA program
were implemented, a potential algorithm could be as follows: if an IED victim has
hypotension after tourniquet application, pelvic binder application, and fluid
resuscitation; and, if evacuation to the operating room will be greater than 20
minutes, then REBOA should be considered (Figure 4.2). Rapid evacuation to a
surgical facility should not be delayed for REBOA insertion. Given that the mean
time to death of patients that would have potentially benefited from REBOA was 75
minutes 14, a patient who could be imminently evacuated would likely derive greater
benefit from rapid access to higher-level surgical care than from delayed evacuation
and REBOA placement.
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Figure 4.2 Potential algorithm for forward medical center REBOA use
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4.1.5 Zone of deployment
The most common REBOA zone of deployment in the civilian setting is Zone 1
(78.6%)18. Deployment in the thoracic aorta will control all hemorrhage below the
level of the diaphragm, much like an aortic cross-clamp in a resuscitative
thoracotomy. The major disadvantage of deployment at this zone is the associated
spinal cord and intestinal ischemia15,22. In the swine model, 30 minutes of occlusion
is well tolerated but by 90 minutes there is evidence of liver necrosis and renal
dysfunction 23. Zone 3 deployment does not offer control of intra-abdominal
hemorrhage; however, it provides excellent control of pelvic and junctional bleeding
without the risk of visceral ischemia9,15. Zone 3 poses fewer technical challenges for
placement, can use shorter wires than with Zone I deployment, and may be an easier
skill to teach and maintain for non-surgeon medical officers. Zone 3 REBOA will
likely be less cumbersome in a more forward environment, and it does not run the
risk of life-threatening visceral ischemia in the context of delayed evacuation. While
personal protective equipment provides some thoraco-abdominal protection, the
injury pattern of the AP-IED is associated with significant pelvic injury that may be
amenable to this technique5. These characteristics make anatomical Zone 3
deployment the most practical location for the pre-hospital combat physician.

4.1.6 Training
REBOA is a new technique to military medicine, with the majority of data on REBOA
coming from trauma and vascular surgeons with considerable endovascular
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experience, working in a civilian setting 18. Many of the pioneers of this technique
espouse caution with its rapid adoption 24. Japan has one of the largest experiences
with REBOA in civilian trauma. In their system, emergency physicians can be
credentialed after performing REBOA three times during residency training 25.
REBOA patients may have their device placed by an emergentologist, and definitive
treatment provided by interventional radiology without direct surgeon involvement
26.

Prospective data from the Japan Trauma Data Bank was used to match REBOA

patients to propensity score-adjusted non-REBOA patients, demonstrating a
decrease in survival in the REBOA patients by an odds ratio of 0.30 (95% confidence
interval, 0.23-0.4) 25. A 24 patient Japanese series demonstrated that REBOA did
increase mean systolic blood pressure, but they encountered complications such as
the balloons not deflating, vascular injury while trying to obtain access, and a 12.5 %
requirement for amputation, one of which arose from an iatrogenic vascular injury
27.

The American experience as captured in the Aortic Occlusion for Resuscitation in

Trauma and Acute Care Surgery (AORTA) registry has only reported three
endovascular specific complications, including distal embolism and pseudoaneurysm; no patients required amputations in the 46 REBOA patients captured by
the registry 18. Early American clinical series did not demonstrate any procedurerelated deaths or major complications 21. Some authors have cautioned against the
widespread adoption of REBOA, fearing that use by less qualified practitioners may
generate poorer outcomes before this technique has been adequately studied and its
indications for use and required provider training have been defined 24. Most
contributors to the American REBOA registries are trauma and vascular surgeons
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who have taken, or are instructors on, REBOA training courses 18,28,29. It is important
that medical officers placing REBOA in combat environments be adequately trained
and their skillset maintained.

A pre-hospital military physician may be a trained surgeon, but more likely will be a
general duty medical officer with experience in central line placement and
ultrasound use, but not in endovascular techniques. Training curricula would need
to be developed with cadaveric and animal models to ensure that these forward
physicians could safely place the device and know which patients may potentially
benefit from the intervention. As mentioned above, an ultrasound-guided
percutaneous technique would likely be the most appropriate. With the
development of smaller caliber devices (7 Fr)12, the possibility of training a medical
officer to safely insert a Zone III REBOA to facilitate transportation of an IED
casualty to a surgical facility is likely an achievable future reality, but we must move
towards this goal with prudence and careful planning supported by robust research.
A strong training curriculum focused on both skillset acquisition and maintenance is
crucial to a successful combat REBOA program.

4.1.7 Future of combat REBOA
Both military and civilian trauma surgical centers are using REBOA for the
treatment of hemorrhaging trauma patients 13,30. Responsibly, these therapies are
being utilized within a framework of active clinical registries and ongoing research
to clarify the use, safety, and indications of this new technique. REBOA as it is
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presently designed is not yet ready for the pre-hospital or combat pre-surgical
environments and should only be used in well-trained hands in an environment
with ready surgical capabilities. However, REBOA does have promise as a forward
medical tool if a new device could be designed to meet the needs of this very
different medical environment. Lives would be saved if a physician at a forward
medical center, with appropriate training and skill set maintenance, was able to
insert a balloon under ultrasound-guidance to occlude the distal aorta of an unstable
casualty to allow them to survive to surgery where they otherwise would have died.
Recent experience in Iraq and Afghanistan demonstrated a 98% survival rate for
those injured soldiers that could be evacuated to a facility with surgical capability 31.
For this reason it is important to develop tools that have the potential to increase
the proportion of battlefield injured that make it to surgical care. If an appropriate
internal tourniquet were designed it would likely be able to save soldiers’ lives,
enabling evacuation to a surgeon’s life-saving care.

4.1.8 Requirements for a combat REBOA device
The REBOA equipment presently available requires insertion wires that are over a
meter long and it needs a large sterile area to control and insert this equipment 9.
That setup is not conducive to a forward combat medical environment. Once
inserted the presently cumbersome setup would not be easily transported in a
medevac helicopter or armored ambulance. Also the person inserting this device
will likely be a physician but not necessarily a surgeon. With the current REBOA
implementations the guide wire must be manipulated up to the aortic zone of
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deployment. If the iliacs have been damaged by an IED blast this could become a
difficult or impossible task. Another pitfall would be if the wire advanced down the
contralateral iliac rather than up the aorta. Inflating a fluid filled balloon in the iliac
or femoral arteries could be a devastating complication. For a combat occlusion
device to be feasible it would have to: be easy to use, have a short wire, be able to be
transported with the patient, be able to manage blast injured pelvic vessels, be able
to tolerate contralateral iliac intubation. We have designed a novel device to meet
these requirements.

4.2 CREATION OF OCCLUSION DEVICE
4.2.1 Methods
A novel device was designed to cause Zone 3 aortic occlusion (Figure 4.3). Rather
than using a Seldinger technique, guiding the apparatus over a wire, a latex balloon
expands up the vessel as it inflates. The device is self-guided. This 16 mm x 22 cm
balloon inflates up the vessel. As the balloon expands it carries a wire that is
attached inside the balloon with it. This allows for a measurement of length of
deployment as well as the application of gentle pressure to facilitate deployment.
The balloon is inflated from a pressurized carbon dioxide (CO2) canister.
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Figure 4.3 Novel iliac and aortic occlusion device

Device construction
A 16 g CO2 canister was used to inflate the balloon. This was attached with a
variable valve allowing for control of inflation and a pressure gauge to monitor
balloon internal pressure (Figure 4.4). A ¼ inch ball valve was used as a pressure
release to allow for deflation of the balloon and retraction of the device (Figure 4.5).
A 1.1 mm diameter braided wire enters the device through a rubber seal of near
identical diameter. When the balloon device is deployed a plastic bead is pulled into
the rubber seal. The more inflated the balloon becomes, the greater of the force of
the bead into the seal preventing air leak. The balloon is 22 cm in length and 1.6 cm
in diameter. It begins invaginated in the device and then inflates and deploys
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longitudinally with CO2 inflation (Figure 4.4). Once maximum length is achieved the
balloon will further distend laterally.

The balloons were fabricated by rolling sheets of 0.05 mm latex onto a dowel and
applying liquid latex along the seam (Figure 4.5). The cylindrical latex tube was then
rolled off the dowel (Figure 4.6) and then attached with epoxy to the braided wire
(Figure 4.7) and invaginated into the device.

Figure 4.4 CO2 inflation devices
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Figure 4.5 Rolling of the latex on the dowel

Figure 4.6 Rolling the balloon off of the dowel
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Figure 4.7 Balloon attached to the braided wire

Occlusion pressure testing
In order to determine against what pressure the device could obtain and maintain
occlusion, a testing model was created (Figure 4.8). This aortic model consisted of a
2 cm diameter vinyl model aorta with 2 cm diameter vinyl iliac limbs that had water
pumped through it at variable pressures (Figure 9). A PSI gauge was placed in
continuity with the water flow to measure how high the water pressure could be
raised maintaining balloon occlusion before rupture. During each experiment the
testing apparatus and the PSI gauge were video taped so that an accurate PSI
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rupture pressure could be recorded and occlusion of flow was confirmed (Figure
4.10). A variable speed pump was used to increase the water pressure until rupture
was obtained and PSI recorded.

Figure 4.8 Aortic occlusion testing apparatus
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Figure 4.9 Un-occluded flow through testing apparatus

Figure 4.10 PSI gauge and camera mount
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In order to determine the internal balloon pressure that would cause rupture, a
pressure gauge was put in series with the device and the balloon was gradually
inflated until the balloon ruptured. The gauge was video taped during the
experiments to ensure accurate pressure recording.

4.2.2 Results
The invaginated balloon of the device would expand out of the tip of the catheter
until it reached its full length (Figure 4.11) and then would further stretch to up to
5.5 cm in diameter (Figure 4.12).

Figure 4.11 Deployed balloon
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Figure 4.12 Further inflation of deployed balloon

The device was deployed into the occlusion pressure testing apparatus (Figure
4.13). Once occlusion had been obtained the upstream water pressure was
gradually increased until the balloon ruptured. The mean rupture pressure was 561
mmHg (SD 124) with the minimum rupture pressure of 362 mmHg, well above any
physiologic human blood pressure (Figure 4.14). The balloon internal pressures
were also measured and as one would expect were equal to upstream pressures at
the time of rupture.

Once the device had been shown to be able to deploy and occlude flow above
physiologic pressures, the deployment apparatus was miniaturized. The final
deployment catheter had an external diameter of 6.35 mm and an internal diameter
of 2.76 mm (Figure 4.15). This device could be deployed in a human sized model
with a 2 cm aorta and 1 cm iliac vessels (Figure 4.16).
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Figure 4.13 Balloon occluding pressure-testing apparatus

Figure 4.14 Balloon rupture pressures
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Figure 4.15 Smaller deployment device

The smaller device was then tested on aortic models of human anatomical scale with
2 cm diameter aortic tubing and 1 cm diameter iliac tubing. The device was
successful in occluding flow in this model.

Figure 4.16 Deployment of the balloon in a human sized aortic model
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4.2.3 Discussion
We have created a device that can be inflated in a human scaled model and cause
occlusion of fluid flow to above human physiologic pressures. It is easy to use
requiring only arterial access and turning on the CO2. The device self inflated and
self guided up the model aorta to cause effective occlusion. The internal wire allows
the measurement of the length of deployment as well as extraction of the device.
The next step was to test the device’s ability to occlude flow in animal tissue and in
damaged iliac models.

4.3 PORCINE MODEL TESTING
4.3.1 Methods
Occlusion of cadaveric porcine aorta
A cadaveric porcine aorta was placed into the testing apparatus, replacing the
artificial tubing. Small arterial branching vessels were suture ligated. The device
was then used to cause flow occlusion and this was video taped. Normal saline was
infused through the testing apparatus during cadaveric porcine experiments. The
porcine aortas were obtained from a local abattoir on the day of slaughter. The
experiments were conducted on the day of slaughter (Figure 4.18).

Modeling damaged iliac vessels
In order to model the balloon progression and occlusion of flow that would occur in
a damaged iliac, a 1 cm diameter defect was cut in the iliac vessel of the porcine
model. The device was then used to inflate up the damaged limb while the
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experiment was video taped. This was done on three different porcine aortas. Three
different balloons were used on each model for a total of nine balloons being tested
(Figure 4.18)

Figure 4.17 Porcine aorta model

Figure 4.18 Porcine aorta with 1 cm diameter iliac defect with device deployed
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4.3.2 Results
The porcine aorta was attached to the perfusion apparatus. The device was
deployed up the porcine iliac and aorta and occluded fluid flow. The balloon device
was successful in occluding flow of water in a porcine aorta model with a perfusion
pressure of 120 mmHg. All nine balloons that were tested were able to provide
effective occlusion.
When a 1 cm defect was cut in the iliac to simulate a traumatically damaged vessel,
the balloon was able to fill the defect and continue on its proximal course to cause
occlusion.
Figure 4.19 Porcine aorta occluded at a perfusion pressure of 120 mmHg
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Figure 4.20 Porcine aorta with iliac defect occlusion testing

4.3.3 Discussion
The device was shown to be able to occlude the flow of fluid through porcine blood
vessels at a fluid pressure of 120 mmHg. Furthermore, when a 1 cm defect was cut
into the iliac the balloon would fill that defect and continue its course up the vessel
to cause more proximal occlusion. This device has shown it can be used on a tissue
model and can navigate a model of iliac injury. By inflating to fill the defect in the
blood vessel it will occlude flow out of that defect. The technique of inserting a Foley
catheter into a junctional injury has already been used in trauma. This device
accomplishes a similar effect at the site of vessel injury with the added advantage of
being able to continue more proximally to provide aortic occlusion. The next step is
to show it can be deployed in human anatomy.
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4.4 PERFUSED HUMAN CADAVERIC TESTING
4.4.1 Methods
Human cadaver had a catheter inserted in their subclavian artery and was perfused
with a water and red dye solution. The cadaver was provided through the
bequeathal program, Department of Anatomy & Cell Biology, Western University,
London, Ontario, Canada, in accordance with the Anatomy Act of Ontario. These
cadavers were never treated with formalin and were preserved by freezing until
they were thawed for the experiments. The femoral arteries were dissected
bilaterally. The device was deployed in the right common femoral artery (Figure
4.21) and flow through the left femoral arteriotomy was observed for occlusion of
flow. The cadavers were perfused to a pressure of 120 mmHg (Figure 4.22).

4.4.2 Results
The device was deployed in the right femoral artery. When it was deployed, flow
through the arteriotomy in the left femoral artery stopped.
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Figure 4.21 Device inserted into a human cadaver

Figure 4.22 Occlusion of flow in a perfused human cadaver

79

4.4.3 Discussion
This device has been tested on a perfused human cadaver model. It has shown that
it can occlude flow of fluid in human blood vessels at a pressure of 120 mmHg. It
was deployed through a cut down and arteriotomy. It has not shown feasibility in a
synthetic aorta, in porcine tissue vessels as well as perfused human vasculature.

4.5 GENERAL DISCUSSION
For a combat occlusion device to be feasible it would have to: be easy to use, have a
short wire, be able to be transported with the patient, be able to manage blast
injured pelvic vessels, and be able to tolerate contralateral iliac intubation. We have
designed a novel device to meet these requirements.

By having the wire internal to the balloon the problem of the guide-wire becoming
extraluminal is alleviated. When advancing a wire through a damaged vessel it could
exit the lumen and create a false passage. With this novel device the operator does
not need to be a skilled endovascular surgeon navigating the wire to the perfect
position before the device can be inserted; instead the balloon leads the way. If the
iliac vessel is injured preventing proximal navigation the balloon will inflate at that
site of injury causing tamponade. This is similar to the previously established
technique of inflating a Foley catheter into a junctional injury for tamponade. If the
device could not be advanced because of iliac injury a second device could be
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inserted into the contralateral side. If again it could not be advanced both can be left
in place causing bilateral iliac tamponade and aiding in hemorrhage control. This is
superior to the tradition REBOA where if the wire cannot be safely advanced the
technique must be aborted.

One of the dangers of standard REBOA application is that the guide wire may
descend down the contralateral iliac artery rather than advance into the aorta. If the
REBOA balloon was then inserted and inflated in the contralateral iliac or femoral
artery, rather than achieving aortic occlusion the procedure would cause further
vascular trauma. In the hands of skilled endovascular surgeons this complication
may be reliably avoided however it is a real concern for forward application of this
tool in combat medicine. The advantage of this device is that if the balloon and its
internal wire do go down the contralateral iliac, bilateral iliac occlusion is safely
obtained as the balloon inflates up one limb and down the other (Figure 4.17). This
feature makes this novel device more suitable for a combat application. The internal
wire inside the balloon can help in gentle navigation and advancement and also be
used to measure depth of balloon expansion without the challenges of classical
Seldinger endovascular technique. Since it is the balloon that gently leads the way
the device will occlude as far as it travels rather than having to perfectly position a
REBOA for deployment.
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Figure 4.23 Balloon with contralateral limb intubation and bilateral occlusion

Traditional REBOA balloons are inflated with saline, not CO2. Although a variant of
this novel device can be produced with hydro-inflation, CO2 inflation has some
advantages. The C02 cartridges are small and light and easily managed. The main
advantage of water inflation is that it is essentially non-compressible. Once the
balloon is inflated and occlusion is achieved the balloon will not be compressed as
blood pressure is restored. With the CO2 inflated balloon as blood pressure
increases the balloon will be compressed and it is possible that more CO2 will need
to be put into the balloon. However, this compressibility is advantageous when
inflating the balloon in a damaged iliac. Rather than ripping apart the vessel with
uncompressible expanding water balloon a gentler and softer compressible balloon
fills the space of the defect while minimizing further destruction of the vessel.
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Having a self-expanding water balloon advance down the iliac to the aorta would
have a higher risk or vessel rupture. The compressibility of CO2 makes it perfect for
this application. As has been demonstrated in our experiments occlusion of flow to
supra-physiologic levels can still be achieved. CO2 is also a good choice in the event
of balloon rupture. This gas is rapidly absorbed and expelled though the lungs. This
is the same reason for its use in laparoscopic surgery. Any gas embolism formed
would be in the distal circulation and unlikely to cause cardiac or brain gas
embolism. CO2 with its small sized containers, ease of use, compressibility and
physiologic absorption make it an ideal choice for this device.

This novel device has a wire that is only 30 cm in length which is much more easily
handled than the 260 cm wires used in standard REBOA9. With the present design
this device requires a short sheath to be inserted into the femoral artery. This is the
same as with REBOA placement. During patient transport of the casualty, care must
be taken not to disturb this sheath. Although this novel device and REBOA share
this challenge, the compact nature of the novel device and the short wire would
make transporting the casualty simpler.
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This novel aortic occlusion device has the advantage of having a shorter wire, being
easier to transport with the patient, being able to provide occlusion to damaged iliac
vessels, and can be inserted bilaterally. With further development and live animal
testing this device may be able to be implemented in a forward environment to help
combat casualties survive to the surgical care.
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CHAPTER 5: GENERAL DISCUSSION
5.1 VASCULAR TRAUMA AND THE AP-IED
Combat vascular trauma is the next area where military medical research can save
lives. Vascular procedures were the fourth most common performed in the
Afghanistan and Iraq wars; however, they were the area in which there was the
biggest change in practice over the course of the conflicts and greatest need for
increased training and innovation.1,2

The IED was the most common weapon to kill and injure Canadian soldiers in the
Afghanistan war. 3 Through prospectively examining 100 consecutive IED victims
we have provided a characterization and medical description of this weapons injury
pattern. The IED causes multiple amputation as well as pelvic fractures and
significant perennial and gluteal injuries. Although tourniquets and pelvic binder
have been very effective in saving the lives of the combat injured 4 if we are going to
save even more soldiers lives we must develop strategies to control the noncompressible hemorrhage caused by these weapons.

5.2 PHYSICIANS AND LAND MINES

War physicians played an integral role in the determination that the use of land mines is
unethical. Land mines are indiscriminate weapons. Unlike a rifle or rocket that is pointed
at its target, a land mine is buried with the hopes that the enemy will detonate it. But the
enemy may not be the first person to step on it. It may be a 12-year-old child or other
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civilian. When a conflict is over, the soldiers pointing their rifles and rockets leave;
however, the land mine remains buried and remains equally as dangerous. Once the war
is over and all the soldiers have left, that 12-year-old child remains in danger from these
weapons.

The lack of discrimination and horrible wounds of land mines prompted the emergence of
public campaigns for them to be banned. The work of advocates like Jody Williams,
Bobby Muller, Princess Diana, and Lloyd Axworthy helped bring together 162 countries
to sign The Convention on the Prohibition of the Use, Stockpiling, Production and
Transfer of Anti-Personnel Mines and on their Destruction (the Ottawa Treaty) 5 in
Ottawa, Canada in 1997. This was viewed as an international and Canadian success story.
The International Campaign to Ban Landmines and Jody Williams were jointly awarded
the Nobel Peace prize in 1997.

What is less well-known are the contributions of Dr Robin Coupland and Dr Adriaan
Korver to the anti-land mine effort. Prior to the publication of their work, surprisingly
little attention had been paid to land mines in the medical literature. Coupland and
Korver described the injury patterns of antipersonnel land mines by reporting and
analyzing the experience with land mines of 13 International Committee of the Red Cross
Hospitals in Asia and Africa. They were able to develop a classification system for the
pattern of land mine injuries and describe what land mines did to their victims 6-8. Their
work provided the medical foundation for the ethical debates surrounding the creation of
the Ottawa Treaty, which would eventually lead to the banning of land mines by 162
countries. They played a vital role in providing medically accurate and experiential
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knowledge of the land mine’s impact on its victims and who the victims were. Only a
physician could have the requisite knowledge and experience to play that role. The
contributions made by Coupland and Korver allowed Canada and the global community
to make an informed decision.

5.3 ETHICAL WAR AND THE LAW OF ARMED CONFLICT
Although horrible suffering occurs during war, the global community has acknowledged
that military necessity cannot be used to justify all violence. Customary Law based on
global practices and principles had long existed; however, these laws of custom began to
be codified as can be seen in the St Petersburg declaration in 1868 and the multiple
Geneva and Hague Conventions. These were attempts to publicly declare what acts
during war would be considered illegal. War is not a lawless state of violence in which
all actions are excused. People fighting wars are not exempt from ethics and the judgment
of right and wrong. The global community has accepted the concept of war crimes, and
people engaging in wars cannot escape ethical and legal accountability.

A prohibition of superfluous injury or unnecessary suffering is a cardinal principle of the
International Court of Justice 9. The St Petersburg declaration, which was concerned with
what weapons would be acceptable in combat, forbade “the employment of arms which
uselessly aggravate the suffering of disabled men.10” This was reaffirmed in the Hague
Conventions, which were some of the first attempts to codify what constituted a war
crime. The Hague Conventions specified that it was “prohibited to employ weapons,
projectiles and material and methods of warfare of a nature to cause superfluous injury or
unnecessary suffering.11” Whereas the St Petersburg Declaration and Hague Conventions
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were defining what ammunition could be used and how wars were to be fought, the
Geneva Conventions defined the humanitarian treatment of war. Here again it was
affirmed that “it is prohibited to employ weapons, projectiles and material and methods
of warfare of a nature to cause superfluous injury or unnecessary suffering.12” Be it in
treaties defining how wars should be fought, or in treaties outlining humanitarian
treatment during war, it has been agreed upon time and again that superfluous injury or
unnecessary suffering is illegal. This prohibition is a part of customary law and
applicable to all parties of any armed conflict 9. Although it may be required in war to
take a life, to intentionally make someone suffer beyond what is necessary to render him
or her hors de combat is wrong. It is a crime.

The horrible consequences of AP-IEDs were ubiquitous in the Afghanistan war. Anyone
who buried one of these weapons would know the violence and injury they were
inflicting on their victims. This knowledge speaks directly to the mental element, or mens
rea, of their crime. The users of these weapons knowingly mutilated their victim causing
injuries far worse than would be required to incapacitate them. The users of this weapon
knew that it was indiscriminate and that civilians or children may be the victims.

The application of unnecessary harm is not universalizable principle. Neither side would
want themselves to be tortured by their enemy. Inflicting more injury than required for
military victory shows no respect for the humanity of your enemy. This is why the
infliction of unnecessary suffering has been universally rejected in the global community.
It fails both a utilitarian calculus and universal application of a deontological rule. There
can be no reasonable ethic that would make it moral to inflict unnecessary suffering.
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5.4 THE ILLEGALITY OF THE AP-IED
It could be argued that the enemy in Afghanistan had no access to conventional weapons
and, given the power and organization of the coalition soldiers, had to revert to using APIEDs. However, even if the objections of the indiscriminate nature of this weapon and
the fact that it will persist beyond the conflict are overlooked, the fact that it has been
designed to cause maximum harm is inexcusable. They could have created a weapon
similar to a land mine that caused foot or limb amputation and each of the soldiers injured
in this way would be incapacitated and removed from the fight. Instead they developed a
weapon that would cause as much injury as possible. In making these weapons they
chose to optimize the harm and damage they could produce.

Whereas antipersonnel land mines cause amputation of the foot or leg resulting in the
incapacitation of the victim, an AP-IED causes multiple amputations, perineal and genital
mutilation, pelvic fractures and extensive soft tissue injury, and significant life long
disability. The doctors who cared for casualties in Afghanistan routinely saw the
destruction and devastation cause by these weapons, and like Coupland and Korver, they
have captured and described the medical details of these patients. 13-16 The next step is to
express moral outrage and protest against the use of these weapons in kind with Jody
Williams, Bobby Muller, Princess Diana and Lloyd Axworthy. Not only do AP-IEDs
have the same indiscriminate harm of land mines, they cause superfluous injury and
unnecessary suffering. Improvised explosive devices are unethical weapons; their users
have committed a war crime.
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5.5 A NOVEL DEVICE
IEDs cause multiple amputations and massive pelvic injury. REBOA has been proposed
as a technique that can treat the non-compressible hemorrhage of the combat injured. A
gap analysis identified that as many as 18.5% of combat casualties might benefit from
aortic occlusion. 17 Given that 98% of the coalition soldiers injured in Afghanistan
survived if they could reach surgical care any device that could control hemorrhage until
a patient can be evacuated to higher care would be of great help and likely save lives.18

The REBOA technique has been used in combat and the patients did survive to be
evacuated to a surgical facility.19 However, this was accomplished by having surgeons
and emergentologists with extra endovascular training in a forward Special Forces
environment. This is not a feasible model for a broad military application. If
endovascular balloon occlusion of the aorta is going to save soldiers’ lives in wars like
we just experienced in Afghanistan, General Duty Medical Officers with family
residency training or Physicians Assistants will have to perform the procedures. If a
practitioner is capable of placing a central line they can use this novel device. It has been
designed expressly for combat application and it will make REBOA more accessible to
forward military operations. The novel device presented here does not require wire
guidance, or x-ray confirmation of placement. The balloon led technique can manage
damaged iliac vessels and rapidly and easily provide aortic occlusion, stopping pelvic
hemorrhage.
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This device may also be useful in a civilian environment. With centralization of vascular
surgeons and clinicians in peripheral hospitals managing and treating fewer elective
vascular surgeries, there has been a loss of skillset in the periphery. Patients with
significant vascular injuries are often rapidly evacuated to a tertiary center for definitive
repair. This novel device with its easy use and promise for navigating injured and
perhaps calcified and aged vessels may have applications stopping hemorrhage for
transport to definitive care. This new technology has the potential to save both military
and civilian lives.

5.6 VASCULAR INJURIES AT A CANADIAN CENTRE

In order to better understand what vascular injuries are encountered in a civilian
Canadian environment a retrospective five-year study was conducted. This demonstrated
that vascular surgeons managed the majority of vascular injuries; however, surprisingly
13 different specialties managed vascular injuries. If there is to be change in the way that
vascular surgery is managed, there must engagement with all of the multidisciplinary
partners who manage these patients.

There are potential areas for improvement in how vascular trauma was managed. A
damage control approach was taken in only one patient out of the 127 examined. The use
of damage control techniques like aggressive ligation and temporary intravascular shunts
may allow sick trauma patients to be able to get to the intensive care unit faster for
correction of their physiologic derangements and then return later for definitive vascular
repair.
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There may be a population that would have benefited from the novel device. There were
29 patients with abdominal and pelvic vascular injuries. Some of these patients may have
been able to have their bleeding controlled in the periphery or in the emergency room,
decreasing their blood loss and physiologic derangement before getting to the operating
room. As this new technology is further developed and its indications refined, the
vascular trauma data collected here will be useful in identifying civilian populations
worth considering for its application.

5.7 FUTURE DIRECTIONS

The three projects which comprise this work each have next steps to be taken. Next
generation prototypes of the new device tested here need to be developed that can be
inserted through a 7 or 8 Fr sheath. This is feasible given that it has been shown to
function in a catheter with an 8 Fr internal diameter. This size is important since its
removal will not require repair of an arteriotomy and can be controlled with direct
pressure. This prototype should be tested on animal models demonstrating its
physiologic effects and safety profile as the next step before eventual human application.
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The Canadian vascular trauma research registry is going to be applied to multiple centers.
At present four other Canadian level 1 trauma centers are in the progress of collecting the
same retrospective data over the same time period. This will allow for a more robust
description of the Canadian vascular trauma experience that can be compared to
American registries.20 It will also allow for intra-Canadian comparison to be done and for
the establishment of a Canadian vascular trauma research network. If this work proves to
be fruitful, a prospective Canadian vascular trauma registry could be established.

There is now a medical description of the injury pattern of the AP-IED and it is much
more serious and devastating than that of the APM. In this instance the next steps are less
of a scientific and more of an ethical and societal nature. Armed with the medical
knowledge of what and AP-IED can do, the medical community and society at large
should oppose the use of these weapons much as they did in opposition to the use of
landmines.
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